CORMEDIX INC. ANNOUNCES FDA DECISION THAT ADVISORY COMMITTEE MEETING FOR NEW DRUG APPLICATION FOR DEFENCATH IS NOT NEEDED
Written by Sam Nelson on November 18, 2020
PDUFA date remains February 28, 2021 Potentially the first antibacterial…
PDUFA date remains February 28, 2021 Potentially the first antibacterial…
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…
Seasoned industry veteran with decades of strategic and commercial leadership…
Berkeley Heights, NJ – October 29, 2020 – CorMedix Inc. (NYSE…
Berkeley Heights, NJ – October 8, 2020 – CorMedix Inc. (NYSE…
Seasoned industry veteran with decades of strategic and commercial leadership…
Berkeley Heights, NJ – September 9, 2020 – CorMedix Inc. (NYSE…
FDA sets PDUFA goal date of February 28, 2021 Potentially…
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…
Berkeley Heights, NJ – August 3, 2020 – CorMedix Inc. (NYSE…
Berkeley Heights, NJ – July 28, 2020 – CorMedix Inc….
Berkeley Heights, NJ – July 27, 2020 – CorMedix Inc….
Priority Review of NDA Requested Berkeley Heights, NJ – July…
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time…
Berkeley Heights, NJ – May 11, 2020 – CorMedix Inc….
Tuesday, May 19th @ 12pm Eastern Time Berkeley Heights, NJ…
Berkeley Heights, NJ – April 22, 2020 – CorMedix Inc….
Company in process of submitting New Drug Application (NDA) for…
Berkeley Heights, NJ – March 6, 2020 – CorMedix Inc….
Berkeley Heights, NJ – February 3, 2020 – CorMedix Inc….